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Background: Management of PDA is one of the most annoying issues in caring extreme preterm infants. The aim was to review recent statistical figures about PDA in Japanese neonatal units from the Neonatal Research Network database of Japan (NRNJ) which covers~70% of extremely preterm infants born in this country.
Methods: Infants with 23-29 gestational weeks who were cared and registered for NRNJ in 2012 were reviewed. Incidence, pharmacological and surgical treatment rates of PDA, as well as its correlation with premature rupture of membranes (PROM), maternal corticosteroids and hypertensive disorder of pregnancy (HDP), respiratory distress syndrome (RDS) and persistent pulmonary hypertension of the newborn (PPHN) were studied.
Results: A total of 3196 infants were studied. Fifty-three percent were diagnosed to have PDA, 66% treated with indomethacin and 11% surgically treated, all of which showed decreasing trends according to gestational weeks. Complication with PROM was in 35% and HDP in 16%, both having effects of lowering PDA incidence. RDS was diagnosed in 77% of infants and PPHN in 7%, both of which had effects of increasing PDA incidence. No parameters showed difference between sexes.
Conclusions: Clinically significant PDA occurred in about half of extremely preterm infants. Two thirds of infants were treated with indomethacin, 16% of which consequently went for surgical treatment. RDS was strongly associated with PDA. PROM and maternal corticosteroids seemed negative risk factors for PDA, either directly or indirectly via suppressing occurrence of RDS.
COST EFFECTIVENESS OF A NEONATAL EARLY DISCHARGE PROGRAMME Aim: To ascertain the economic impact of NED. Method: Data was prospectively collected on a cohort of 31 babies who received NED. A control group of 37 babies who fulfilled the criteria for NED but where the parents decided against that option or were out of area provided comparative length of stay data. Babies who fulfilled the criteria for NED were healthy infants, generally 2-2.5 kg whose major reason for being in hospital was a need for gavage feeding. If transferred to another hospital for convalescence, these babies would have been allocated DRG P66C on discharge. The measured costs of all babies discharged with DRG P66C from the FMC neonatal unit over the 2 year period July 2016 -June 30th 2017 were utilised to develop a mean daily cost.
Results: The mean reduction in length of stay was 11 days. There were 117 babies discharged to NED over the 2 years. The mean cost of babies discharged with DRG P66C was $1380/day. Analysis of 58 babies/ per annum discharged to NED resulted in a reduction in inpatients cost of $888 030/per annum. The total NED expenditure over 2 years was $118 073/ per annum. The cost saving/ per annum attributable to NED was $770 000 / annum.
Conclusions: The NED program saves a substantial amount of money that would otherwise been spent on longer hospitalisation of these infants. Background: Oxygen therapy facilitates discharge of infants with chronic lung disease from the NICU. The primary indication for home oxygen therapy (HOT) is chronic lung disease (CLD), of prematurity. Other neonatal indications for home oxygen therapy include congenital heart disease, pulmonary hypertension or neuromuscular disease. As HOT requires considerable by multiple discipline and investment of clinical resources, there is a need to better understand the prescribing pattern for infants being discharged from the NICUs.
HOME OXYGEN THERAPY FOR POPULATION OF INFANTS DISCHARGED FROM INTENSIVE CARE IN AUSTRALIA AND NEW ZEALAND
Methods: Anonymised demographic and clinical data was obtained from the ANZNN registry which audits outcomes of infants treated in the NICU. The population of admissions from 1995 to 2015 was studied. Analyses (including logistic regression) were performed using Stata I/C 14.2.
Results: Of the 174 722 infants, 5633 (3.2%) were discharged on oxygen therapy. 61% were male. 68% (3857/5633) of these were infants <32 weeks gestation with CLD. 900 infants were > 32 weeks gestation, representing 16% of HOT group; and 763 did not have CLD with other indications for oxygen therapy. Annual rate of HOT was median of 3.2% (2.3-4.7) with no significant yearly trend. Significant risk factors were growth restriction OR 1.4 (95%CI 1.3-1.5), gestation (weeks) OR 0.9 (95%CI 0.89-0.93), pneumothorax OR 1.4 (95%CI 1.2-1.6), INO use OR 2.1 (95%CI 1.9-2.4) and .
Conclusions: Preterm infants with remain the main group discharged on home oxygen, while late preterm/term infants even without CLD remain an important group. The rate of home oxygen at discharge appears to be stable over past two decades.
